BCL10 Antikörper (N-Term)
-
- Target Alle BCL10 Antikörper anzeigen
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BCL10 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- BCL10 antibody was purified by affinity chromatography
- Immunogen
- BCL10 antibody was raised in Rabbit using a synthetic peptide corresponding to a sequence at the N-terminal of human BCL10, identical to the related rat and Rabbit sequences, as the immunogen
- Isotyp
- IgG
- Top Product
- Discover our top product BCL10 Primärantikörper
-
-
- Applikationshinweise
- Optimal conditions to be determined by the end user
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- Lot specific
- Buffer
- lyophilized form
- Handhabung
- Avoid repeated freeze/thaw cycles
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at 4 °C for short term storage. For long term storage aliquot and store at -20 °C,
-
- Target
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
- Andere Bezeichnung
- BCL10 (BCL10 Produkte)
- Pathways
- T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteine
-